Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 70 | $275.17 | $19,261.90 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 8 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred5 at a weighted average price of $275.17 (range $275.07 to $275.30). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 210 | $274.41 | $57,626.10 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 7 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,002 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred5 at a weighted average price of $274.41 (range $274.05 to $274.65). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 240 | $273.53 | $65,647.20 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 6 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,212 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $273.53 (range $273.03 to $273.90). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 328 | $272.40 | $89,347.20 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 5 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,452 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $272.40 (range $272.03 to $272.98). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 149 | $270.51 | $40,305.99 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,780 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $270.51 (range $270.00 to $270.75). Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 79 | $269.41 | $21,283.39 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,929 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $269.41 (range $268.97 to $269.87). F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionCommon Stock | 611 | $155.57 | $95,053.27 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:26 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionCommon Stock | 465 | $187.53 | $87,201.45 |
DisclosureSEC source: 0001209191-20-027904 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,356 | $0.00 Strike: $131.89 | $0.00 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · derivative · entry 24 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,334 Underlying: Common Stock · 13,356 shares Expires 2025-07-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: Fully vested. Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 200 | $273.59 | $54,718.00 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 18 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,103 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F14 · price: Open market sales reported on this line occurred at a weighted average price of $273.59 (range $273.50 to $273.67). Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 403 | $272.58 | $109,849.74 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 17 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,303 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F13 · price: Open market sales reported on this line occurred at a weighted average price of $272.58 (range $272.35 to $272.83). Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 100 | $271.09 | $27,109.00 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 16 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,706 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 11,553 | $270.01 | $3,119,425.53 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 15 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,806 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F12 · price: Open market sales reported on this line occurred at a weighted average price of $270.01 (range $269.98 to $270.87). Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 700 | $269.08 | $188,356.00 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 14 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,359 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F11 · price: Open market sales reported on this line occurred at a weighted average price of $269.08 (range $268.76 to $269.53). Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 300 | $267.34 | $80,202.00 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 13 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,059 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F10 · price: Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.11 to $267.67). Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
SaleCommon Stock | 100 | $265.72 | $26,572.00 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 12 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,359 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| May 05, 2020 Filed May 6, 2020 20:43 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Exercise / conversionCommon Stock | 13,356 | $131.89 | $1,761,522.84 |
DisclosureSEC source: 0001209191-20-027496 · doc4.xml · nonDerivative · entry 11 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,349 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · derivative · entry 18 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,697 Underlying: Common Stock · 24,349 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Fully vested. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,470 | $0.00 Strike: $91.05 | $0.00 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · derivative · entry 17 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,806 Underlying: Common Stock · 4,470 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Fully vested. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 35,502 | $0.00 Strike: $96.87 | $0.00 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · derivative · entry 16 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,998 Underlying: Common Stock · 35,502 shares Expires 2024-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Fully vested. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,216 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · derivative · entry 15 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,431 Underlying: Common Stock · 24,216 shares Expires 2029-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Fully vested. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 5,375 | $273.70 | $1,471,137.50 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 13 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,656 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F11 · price: Open market sales reported on this line occurred at a weighted average price of $273.70 (range $273.42 to $274.06). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 12,849 | $272.97 | $3,507,391.53 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 12 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,031 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F10 · price: Open market sales reported on this line occurred at a weighted average price of $272.97 (range $272.42 to $273.41). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 11,832 | $272.12 | $3,219,723.84 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 11 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,880 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $272.12 (range $271.42 to $272.41). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 6,003 | $270.86 | $1,625,972.58 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 10 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,712 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $270.86 (range $270.26 to $271.23). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 15,681 | $269.56 | $4,226,970.36 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 9 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,715 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $269.56 (range $269.24 to $270.09). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 22,613 | $268.86 | $6,079,731.18 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 8 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,396 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $268.86 (range $268.23 to $269.22). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 10,878 | $267.62 | $2,911,170.36 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 7 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,009 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $267.62 (range $267.16 to $268.14). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 4,921 | $266.66 | $1,312,233.86 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 6 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,887 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $266.66 (range $266.16 to $267.14). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
SaleCommon Stock | 4,220 | $265.57 | $1,120,705.40 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,808 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $265.57 (range $265.16 to $266.10). F3 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 24,349 | $155.57 | $3,787,973.93 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 4,470 | $91.05 | $406,993.50 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 3 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 35,502 | $96.87 | $3,439,078.74 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:24 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 24,216 | $187.53 | $4,541,226.48 |
DisclosureSEC source: 0001209191-20-027672 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,330 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · derivative · entry 7 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,990 Underlying: Common Stock · 2,330 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 193 | $264.78 | $51,102.54 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · nonDerivative · entry 6 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,902 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $264.78 (range $264.68 to $264.89). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 500 | $262.45 | $131,225.00 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,095 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $262.45 (range $262.11 to $263.09). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 237 | $261.31 | $61,930.47 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,595 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $261.31 (range $260.88 to $261.56). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 700 | $260.17 | $182,119.00 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · nonDerivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,832 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $260.17 (range $259.88 to $260.64). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 700 | $259.18 | $181,426.00 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,532 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $259.18 (range $258.74 to $259.63). F3 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:17 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 2,330 | $86.52 | $201,591.60 |
DisclosureSEC source: 0001209191-20-027464 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,330 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · derivative · entry 7 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,990 Underlying: Common Stock · 2,330 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 181 | $264.82 | $47,932.42 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · nonDerivative · entry 6 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,838 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $264.82 (range $264.77 to $264.89). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 554 | $262.48 | $145,413.92 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · nonDerivative · entry 5 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,019 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $262.48 (range $261.98 to $262.94). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 195 | $261.21 | $50,935.95 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · nonDerivative · entry 4 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,573 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $261.21 (range $260.88 to $261.56). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 700 | $260.16 | $182,112.00 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · nonDerivative · entry 3 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,768 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $260.16 (range $259.74 to $260.64). Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
SaleCommon Stock | 700 | $259.19 | $181,433.00 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · nonDerivative · entry 2 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,468 F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $259.19 (range $258.74 to $259.63). F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:25 UTC |
Parini MichaelEVP, Chief Adm, Leg & BD Off
|
Exercise / conversionCommon Stock | 2,330 | $86.52 | $201,591.60 |
DisclosureSEC source: 0001209191-20-027472 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, Chief Adm, Leg & BD Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:27 UTC |
Silva Paul MSVP & Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 809 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-20-027476 · doc4.xml · derivative · entry 8 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,427 Underlying: Common Stock · 809 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| May 04, 2020 Filed May 6, 2020 20:27 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 59 | $264.75 | $15,620.25 |
DisclosureSEC source: 0001209191-20-027476 · doc4.xml · nonDerivative · entry 6 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $264.75 (range $264.59 to $264.89). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.